1-1-diphenyl-2-picrylhydrazyl has been researched along with Cerebrovascular-Disorders* in 2 studies
2 other study(ies) available for 1-1-diphenyl-2-picrylhydrazyl and Cerebrovascular-Disorders
| Article | Year |
|---|---|
Synthesis and Bioactivity Characterization of Scutellarein Sulfonated Derivative.
Scutellarin ( Topics: Animals; Antioxidants; Apigenin; Biphenyl Compounds; Brain Ischemia; Cerebrovascular Disorders; Chromans; Erigeron; Fibrinolytic Agents; Free Radical Scavengers; Glucuronates; Humans; Male; Picrates; Rabbits; Solubility | 2017 |
Synthesis and bio-activity evaluation of scutellarein as a potent agent for the therapy of ischemic cerebrovascular disease.
Scutellarein, the main metabolite of scutellarin in vivo, has relatively better solubility, bioavailability and bio-activity than scutellarin. However, it is very difficult to obtain scutellarein in nature compared with scutellarin. Therefore, the present study focused on establishing an efficient route for the synthesis of scutellarein by hydrolyzing scutellarin. The in vitro antioxidant activities of scutellarein were evaluated by measuring its scavenging capacities toward DPPH, ABTS(+•), (•)OH free radicals and its protective effect on H(2)O(2)-induced cytotoxicity in PC12 cells using MTT assay method. The results showed that essential point to the synthesis was the implementation of H(2)SO(4) in 90% ethanol in N(2) atmosphere; scutellarein had stronger antioxidant activity than scutellarin. The results have laid the foundation for further research and the development of scutellarein as a promising candidate for ischemic cerebrovascular disease. Topics: Animals; Apigenin; Benzothiazoles; Biphenyl Compounds; Cell Survival; Cerebrovascular Disorders; Free Radical Scavengers; Glucuronates; Hydrogen Peroxide; Ischemia; PC12 Cells; Picrates; Rats; Sulfonic Acids | 2011 |